Publications by authors named "Lisbet Westergaard"

Claim this Profile
P
Pharmacokinetic Characteristics of a Once-Weekly Combination Therapy of Insulin Icodec and Semaglutide Versus Its Separate Components in Chinese Individuals with Type 2 Diabetes.
Fangfang Wang, Zijian Luan, Raluca Maltesen, Asbjørn T Reenberg, Lisbet Westergaard

Diabetes Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic properties of once-weekly insulin icodec in Chinese individuals with type 2 diabetes.
Yijun Li, Ariel Fu, Shan Jiang, Ann-Katrine Kjærsgaard Jøns, Beibei Liang, Lisbet Westergaard

J Diabetes Investig· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic Properties of a Once-Weekly Fixed-Ratio Combination of Insulin Icodec and Semaglutide Compared with Separate Administration of Each Component in Individuals with Type 2 Diabetes Mellitus.
Lisbet Westergaard, Lene Alifrangis, Stephen T Buckley, Hans Veit Coester, Thomas Klitgaard

Clin Drug Investig· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin detemir is characterized by a more reproducible pharmacokinetic profile than insulin glargine in children and adolescents with type 1 diabetes: results from a randomized, double-blind, controlled trial.
Thomas Danne, Nicolin Datz, Lars Endahl, Hanne Haahr, Claudia Nestoris, Lisbet Westergaard

Pediatr Diabetes· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NN2211: a long-acting glucagon-like peptide-1 derivative with anti-diabetic effects in glucose-intolerant pigs.
Ulla Ribel, Marianne O Larsen, Bidda Rolin, Richard D Carr, Michael Wilken, Lisbet Westergaard

Eur J Pharmacol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of conformational restriction in the C-terminus of growth hormone secretagogues on their potency.
Bernd Peschke, Michael Ankersen, Michael Bauer, Thomas Kruse Hansen, Birgit Sehested Hansen, Lisbet Westergaard

Eur J Med Chem· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis